MLMeng Lyu

Meng Lyu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Meng Lyu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Construction and characterization of a muon trigger detector for the PSI muEDM experiment

    by Guan Ming Wong, Tianqi Hu, Samip Basnet, Chavdar Dutsov, Siew Yan Hoh, David Höhl, Xingyun Huang, Timothy David Hume, Johannes Alexander Jäger, Kim Siang Khaw, et al.

    We present the upgraded design, construction, and beam test results for the muon trigger detector (MTD) developed for the muon electric dipole moment (muEDM) experiment at the Paul Scherrer Institute (PSI) in Switzerland. This experiment aims to improve the sensitivity of the muon EDM measurement by more than three orders of magnitude beyond the current limit established by the BNL Muon $$g-2$$ g - 2 experiment. Precise identification of storable incoming muons at the entrance of the storage solenoid is essential, as the MTD must rapidly trigger a pulsed magnetic kicker to confine muons in the central region of the solenoid, where a weakly focusing magnetic field is maintained. The MTD comprises two subsystems: a 0.1 mm-thick plastic scintillator “gate detector” read out by four silicon photomultipliers (SiPMs), and a 5 mm-thick CNC-machined plastic scintillator “active aperture detector” read out by six SiPMs. The geometry of the active aperture detector was optimized through acceptance studies to maximize both storage efficiency and background veto efficiency. Integrated fast electronics generate an LVTTL trigger signal under an anti-coincidence condition – a muon detected in the gate but not in the aperture – ensuring selective triggering of storable muon events for the EDM measurement. The system was tested at the PSI $$\pi $$ π E1 beamline using 22.5 MeV/ c muons under scaled-down conditions to characterize detector response and trigger performance. A Geant4 simulation incorporating detailed optical photon transport and SiPM response modeling was developed and reproduces the measured event topologies with $${\sim }97\%$$ ∼ 97 % agreement. These results validate the detector design and demonstrate the MTD’s readiness for deployment in the full muEDM Phase-1 setup.

  • Top Cited Papers
    Open Access

    Potential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses

    by Xufei Luo, Fengxian Chen, Di Zhu, Ling Wang, Zijun Wang, Hui Liu, Meng Lyu, Ye Wang, Qi Wang, Yaolong Chen

    Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.


  • Open Access

    Potential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses (Preprint)

    by Xufei Luo, Fengxian Chen, Di Zhu, Ling Wang, Zijun Wang, Hui Liu, Meng Lyu, Ye Wang, Qi Wang, Yaolong Chen

    UNSTRUCTURED Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.

  • Open Access

    Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review

    by Meng Lv, Xufei Luo, Quan Shen, Ruobing Lei, Xiao Liu, Enmei Liu, Qiu Li, Yaolong Chen

    Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in children and adolescents. Methods: We conducted a systematic review of published studies and ongoing clinical studies related to the safety, immunogenicity, and efficacy of COVID-19 vaccine in children or adolescents (aged < 18 years). Databases including PubMed, Web of Science, WHO COVID-19 database, and China National Knowledge Infrastructure (CNKI) were searched on 23 July 2021. International Clinical Trials Registry Platform (ICTRP) was also searched to identify ongoing studies. Results: Eight published studies with a total of 2852 children and adolescents and 28 ongoing clinical studies were included. Of the eight published studies, two were RCTs, two case series, and four case reports. The investigated COVID-19 vaccines had good safety profiles in children and adolescents. Injection site pain, fatigue, headache, and chest pain were the most common adverse events. A limited number of cases of myocarditis and pericarditis were reported. The RCTs showed that the immune response to BNT162b2 in adolescents aged 12–15 years was non-inferior to that in young people aged 16–25 years, while with 3 μg CoronaVac injection the immune response was stronger than with 1.5 μg. The efficacy of BNT162b2 was 100% (95% CI: 75.3 to 100), based on one RCT. Of the 28 ongoing clinical studies, twenty-three were interventional studies. The interventional studies were being conducted in fifteen countries, among them, China (10, 43.5%) and United States(9, 39.1%) had the highest number of ongoing trials. BNT162b2 was the most commonly studied vaccine in the ongoing trials. Conclusion: Two COVID-19 vaccines have potential protective effects in children and adolescents, but awareness is needed to monitor possible adverse effects after injection. Clinical studies of the COVID-19 vaccination in children and adolescents with longer follow-up time, larger sample size, and a greater variety of vaccines are still urgently needed.